What is Biliary Atresia

Biliary Atresia is a rare, life-threatening pediatric liver disease where the bile ducts inside or outside the liver are blocked or absent, preventing bile from draining into the intestines. This obstruction causes bile to accumulate in the liver, leading to rapid scarring (fibrosis) and liver failure if not treated surgically early in life. With 342 members on DiseaseMaps.org, we recognize the profound impact this condition has on families worldwide.

What happens to the body in Biliary Atresia?

In a healthy infant, bile travels from the liver through a system of ducts to the gallbladder and small intestine, where it aids in digestion. In Biliary Atresia, this drainage system is damaged or obstructed. When bile cannot exit the liver, it builds up and acts like a toxin, causing inflammation and progressive scarring known as biliary cirrhosis. Because the liver is responsible for filtering blood, synthesizing proteins, and processing nutrients, the structural damage caused by Biliary Atresia can lead to jaundice, poor growth, and, if left untreated, end-stage liver disease.

What causes Biliary Atresia and who is affected?

The exact cause of Biliary Atresia remains a subject of intense medical research. It is generally not considered an inherited genetic condition. Most experts believe it is caused by an inflammatory or autoimmune process triggered by a viral infection or exposure to toxins during late pregnancy or shortly after birth. While the disease is rare, it is the most common reason for liver transplantation in children. Key epidemiological facts include:

• Incidence: It occurs in approximately 1 in 8,000 to 1 in 15,000 live births globally.


• Gender distribution: Some studies suggest a slight female predominance.


• Age of onset: Symptoms typically appear between two weeks and two months of age.


• Geographic variation: Higher incidence rates have been reported in parts of Asia compared to Europe or North America.

How is Biliary Atresia classified?

Clinicians generally categorize Biliary Atresia based on the timing of onset and the anatomical location of the obstruction:

1. Perinatal (Isolated) Biliary Atresia: The most common form (80-90% of cases), where the infant appears healthy at birth and develops jaundice a few weeks later.


2. Embryonic (Fetal) Biliary Atresia: A rarer form (10-20% of cases) often associated with other congenital anomalies, such as heart defects or malrotation of the intestines.

What differentiates Biliary Atresia from other liver conditions?

What makes Biliary Atresia unique is the critical "golden window" for intervention. Unlike neonatal jaundice, which is common and often resolves on its own, jaundice that persists beyond two weeks of age is a clinical red flag. If a child has Biliary Atresia, the Kasai procedure (a surgery to reconnect the liver to the intestine) is most effective when performed before the infant is 60 days old. Delays in diagnosis significantly impact the long-term prognosis and the likelihood of needing a liver transplant later in childhood.

Next steps

• Consult a pediatric hepatologist or a pediatric surgeon immediately if your infant has prolonged jaundice or pale/acholic stools.


• Join the Biliary Atresia community on DiseaseMaps.org to connect with 342 other families navigating this journey.


• Request a referral to a high-volume transplant center, as early surgical intervention is the gold standard for management.


• Review resources from the American Liver Foundation or the Children’s Liver Disease Foundation for specialized care guidelines.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.

References

• NIH GARD: Biliary Atresia (rarediseases.info.nih.gov)


• Orphanet: Biliary Atresia (orpha.net)


• OMIM: Biliary Atresia (omim.org)


• American Liver Foundation: Biliary Atresia Information (liverfoundation.org)